Gene Query: IFNAR2

Dataset Description Geneva Score
Lentiviral CRISPR Epigenome Editing of Inflammatory Receptors as a Gene Therapy Strategy for Disc Degeneration 60.21
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells 53.9
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes 34.88
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 25.35
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 22.86
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 22.83
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 21.51
Human RELA haploinsufficiency results in autosomal dominant chronic mucocutaneous ulceration: the transcriptional profile of RelA haploinsufficient patients 21.35
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 21.29
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 20.22
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 19.17
MiR-26 dampens IL-6 production by down-regulating TNF-a/NF-kB signaling through silencing HMGA1 and MALT1 and not by directly targeting IL-6 mRNA 18.73
Transcriptional Signatures of Hypoxic and Inflammatory Renal Epithelial Injury 17.98
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 17.94
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 16.62
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 16.62
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 15.65
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 15.09
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 15.09
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 14.91
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 14.76
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 14.76
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells (Poly(I:C) and LPS) 14.17
Pharmacologic inhibition of STAT5 in AML 13.76
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 13.73
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 13.73
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 13.64
Hijacking of stress response machinery by oncogenes in acute leukaemia 13.64
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte [RNA-seq] 13.54
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte 13.54
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 13.25
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 13.25
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 13.16
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 13.12
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 13.1
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 13.03
Transcriptional responses of human insulinoma cells to acute cytokine exposure 12.97
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 12.72
KLF6-dependent transcription in renal cancer cells 12.58
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 12.22
Transcriptome-wide identification of CELF2 functional targets in T cells 12.03
Cleavage Factor Im as a key regulator of 3’ UTR length 11.96
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 11.73
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 11.58
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 11.0
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 10.93
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 10.89
RIG-I and MDA5 fRIP during KSHV lytic reactivation 10.78
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 10.72
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 10.67
Gene expression profile of multiple myeloma cell lines treated with CB-5083 10.62
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 10.55
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 10.5
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 10.08
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 9.8
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 9.78
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 9.78
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 9.77
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) 9.54
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics 9.54
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 9.44
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 9.24
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 9.24
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 9.24
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing [RNA-seq] 9.22
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing 9.22
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 8.88
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 8.75
Gene expression analysis of immortalized human liver progenitor-like cells in culture 8.67
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 8.62
Identification of Nrf2 regulated genes by RNA sequencing 8.54
Nrf2 regulated genes in A549 cells 8.54
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 8.44
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 8.43
Transcriptomic of MKD (MUC1 kidney disease) patient compares to normal derived kidney epithelial cells 8.36
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 8.29
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 8.29
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 8.21
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 8.16
A map of gene expression in neutrophil-like cell lines 8.12
Selective suppression of endothelial cytokine production by progesterone receptor [RNA-seq] 8.0
Selective suppression of endothelial cytokine production by progesterone receptor 8.0
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 7.92
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 7.92
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 7.88
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 7.87
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 7.83
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 7.76
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 7.72
IRF2 is a master regulator of human keratinocyte stem cell fate 7.72
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 7.7
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 7.63
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 7.53
Long non-coding RNAs are central regulators of the IL-1b-induced inflammatory response in human lung fibroblasts 7.43
CROP-Seq in Primary Human T Cells 7.42
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 7.4
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 7.33
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 7.25
Be1 and Be2 B cells are transcriptionally distinct 7.22
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 7.21
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 7.2
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 7.19
Genome-wide analysis of Dengue virus 2 infected cells 7.17
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 7.05
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 7.01
The evolution of N6-methyladenosine in primates 6.96
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 6.94
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 6.9
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 6.9
RNA-seq analysis of AML cells in response to ASLAN003 6.86
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 6.86
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 6.86
RNA-seq of cancer-associated fibroblasts (CAF) treated with PBS or extracellular vesicles (EV) from MCF10A or MDA-MB-231 cells 6.82
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation 6.76
Integrating single-cell transcriptomic data across different conditions, technologies, and species 6.72
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 6.68
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 6.68
Primary human trophoblast from term placenta 6.67
TLR2 dimerization blockade allows generation of homeostatic intestinal macrophages under acute colitis challenge 6.65
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 6.64
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 6.6
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 6.6
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 6.59
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 6.57
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 6.55
Primary Human B-cell Temporal Response to CD40L Stimulation 6.52
SRSF2 mutations impair hematopoiesis and alter exon recognition 6.52
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 6.48
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 6.45
Transcriptomes of human monocytes after ex vivo exposure to uric acid 6.44
MicroRNA-125a-5p overexpression in human macrophages 6.39
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 6.36
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 6.19
Transcriptomic analysis of human tonsillar TFH subsets 6.17
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 6.15
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 6.13
RNA-seq data from human lymphoma cell lines 6.09
ChIP-seq and RNA-seq from human lymphoma cell lines 6.09
RNA-Sequencing of HepG2 cells treated with TGFBeta 6.08
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 5.99
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 5.94
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 5.94
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 5.93
Regulating Interleukin-2 activity with engineered receptor signaling clamps 5.93
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 5.92
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 5.92
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 5.88
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 5.87
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 5.85
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 5.85
Peptidomimetic blockade of MYB in acute myeloid leukemia 5.85
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 5.85
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 5.84
Human Treg IL-12 stimulation 5.84
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 5.83
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 5.8
Landscape of H3K4me3 in human CD19 cells 5.79
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 5.7
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 5.69
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 5.66
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 5.66
Transcriptional profiles of normal human mature B cells 5.62
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 5.61
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 5.61
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 5.55
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 5.55
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 5.52
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 5.5
Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells 5.5
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 5.46
High-Throughput Kinetic Analysis of Fractional Killing 5.43
Global response to chemotherapy-induced apoptosis 5.42
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 5.42
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 5.38
RNA sequencing of BT142 and TS603 cell lines 5.38
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 5.37
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 5.31
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 5.28
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 5.25
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 5.23
RNA sequencing of hPSC-derived cardiac progenitors and endocardium 5.19
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 5.15
Tpl-2 and MEK small molecule inhibitors 5.1
Tpl-2 small molecule project 5.1
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 5.1
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 5.06
Identification of renal resident macrophages across species 5.05
MYOD Remodeling of the Genome Architecture during Myogenic Conversion of Somatic Cells 4.99
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 4.94
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 4.93
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 4.88
GATA3-mediated chromatin reprogramming in breast cancer cells 4.88
An optimization system for isolating and sequencing of single human colon cancer cells 4.87
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 4.83
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 4.81
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 4.81
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 4.79
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 4.79
CD86 regulates a pro-survival signal in myeloma cells 4.72
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 4.71
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 4.63
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 4.61
STX4 Over-Expression in Human islets 4.6
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 4.54
Expression and functions of long noncoding RNAs during human T helper cell differentiation 4.54
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma 4.53
RNA sequencing with KSHV infection and enrichment for circular RNAs 4.53
Microglia innatly develop within cerebral organoids 4.51
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 4.49
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 4.49
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 4.48
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 4.44
Chromatin-informed inference of transcriptional programs in gynecologic cancers 4.44
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 4.43
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 4.43
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 4.4
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 4.4
Generation of induced keratinocyte stem cells from human urine cells by defined transcription factors 4.39
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 4.39
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 4.36
Human cells contain natural double-stranded RNAs with potential regulatory capacity 4.35
Human Treg NaCl stimulation 4.35
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 4.35
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 4.29
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 4.29
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 4.27
Transcriptome of Stabilin-1 siRNA transfected human monocytes 4.26
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 4.24
Analysis of Combined Transcriptomes Identifies Gene Modules Differentially Responding to Pathogenic Stimulation in Vascular Smooth Muscle and Endothelial Cells 4.24
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 4.24
Seletive inhibition of CDK9 in DLBCL cell lines 4.2
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 4.17
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 4.16
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 4.1
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 4.09
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 4.07
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 4.07
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 4.06
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 4.05
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 4.01
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 3.99
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 3.99
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 3.97
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 3.96
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 3.96
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 3.96
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 3.96
Re-Wiring 3D Nuclear Architecture by a Single Transcription Factor during Somatic Cell Reprogramming 3.94
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 3.94
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 3.94
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 3.93
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 3.93
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 3.91
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 3.91
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 3.89
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 3.85
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 3.82
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 3.78
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 3.77
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 3.76
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 3.73
Total RNA-seq in ALL-SIL upon TLX1 knockdown 3.73
Effect of ILF3 on translation during homeostasis and the antiviral response 3.71
Defective structural RNA processing in relapsing-remitting multiple sclerosis 3.67
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 3.65
Human interleukin-4 treated regulatory macrophages promote epithelial wound healing and reduce colitis in an mouse model 3.64
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 3.63
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 3.62
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 3.61
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 3.61
CD73 knockdown effect in pancreatic cancer cell lines 3.57
MYC dependent mRNA translation shapes gene expression and cell biology 3.56
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 3.55
Macrophage Ad5f35 M2 Challenge 3.53
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 3.53
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 3.51
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 3.51
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 3.46
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 3.46
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 3.45
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 3.43
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 3.43
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 3.42
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 3.4
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 3.39
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 3.34
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 3.33
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 3.33
mRNA expression levels in splenic human mononuclear cells of mock- and HIV-1-infected humanized mice 3.33
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene (RNAseq) 3.32
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene 3.32
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 3.3
Effect of MDK expressing Melanoma cells conditioned media in Human LEC 3.3
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 3.26
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 3.24
Transcription profile analysis of wild type and Irf9-/- human monocytic THP1 cells in response to type I interferons 3.24
Irf9 function in immunity in mouse 3.24
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 3.23
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 3.18
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 3.16
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 3.16
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.11
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 3.11
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 3.11
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 3.11
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 3.11
Transcription control by the ENL YEATS domain in acute leukemia 3.1
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 3.1
Effect of PRDM11 depletion in U2932 cells 3.08
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 3.07
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes 3.06
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes (RNA-seq) 3.06
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 3.06
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 3.06
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 3.03
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation 3.02
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 3.02
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 3.01
Transcriptomic profiling of human peripheral blood-derived mast cells 3.01
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 3.0
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 3.0
Human neutrophil genome during PMA- and E. coli encounter-induced activation 2.98
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 2.98
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 2.98
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 2.94
Trascriptome of thyroid cancer-induced macrophages 2.87
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 2.87
Cancer-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 2.85
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 2.81
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 2.77
Differential susceptibility of human pleural and peritoneal mesothelial cells to asbestos exposure 2.72
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 2.71
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 2.71
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 2.66
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 2.64
Transcriptome wide analysis of classically and alternatively activated macrophages 2.62
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 2.54
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 2.52
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes [RNA-seq] 2.52
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes 2.52
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 2.49
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 2.49
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 2.49
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 2.44
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 2.37
Gene expression signatures of innate lymphoid cells from human blood 2.34
RNA-Seq in neutrophils from Antiphospholipid Syndrome 2.31
Transcriptome sequencing of differentially expressed genes in mouse and human skin with and without NCSTN mutation 2.3
Transcriptome sequencing of differentially expressed genes in acne inversa (AI) patients with NCSTN mutation and healthy individuals 2.3
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 2.29
Human Treg IFNg/IL-10 subpopulations 2.26
ZIKV infection of monocytes activates inflammasome pathways 2.24
Transcriptome of diurnal human blood neutrophils 2.23
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia (RNA-Seq) 2.22
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia 2.22
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 2.21
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 2.2
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 2.18
Transcriptome Profiling of Influenza A Virus-infected Lung Epithelial (A549) Cells with Lariciresinol-4-β-D-glucopyranoside Treatment 2.16
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 2.15
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 2.12
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 2.11
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 2.06
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 2.06
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 2.06
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 2.06
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 2.05
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 2.04
Short and long-term effects of CDK4/6 inhibition on early stage breast cancer 1.99
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 1.98
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 1.98
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 1.95
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 1.95
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 1.91
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 1.88
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 1.86
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 1.85
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 1.85
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 1.81
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 1.81
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 1.78
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 1.78
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 1.75
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 1.74
Small-molecule targeting of brachyury transcription factor addiction in chordoma 1.74
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 1.73
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 1.73
Functional significance of the HIV-1 Tat signature amino acid residues 1.72
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 1.71
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 1.71
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 1.71
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) 1.69
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent 1.69
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 1.68
Polarized B -cell functions 1.65
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 1.64
Primate transcript and protein expression levels evolve under compensatory selection pressures 1.56
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 1.56
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 1.54
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 1.53
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 1.49
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 1.49
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 1.46
Hepatosplenic T cell lymphoma 1.44
Integrative Genomic and Transcriptomic Analysis Identified Candidate Genes Implicated in the Pathogenesis of Hepatosplenic T-cell Lymphoma 1.44
Frailty in middle age is associated with race-specific changes to the transcriptome. 1.43
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 1.38
MARCKS and lnc-MARCKS act as inflammation regulators 1.38
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 1.38
Transcriptome analysis of peripheral blood monocytes 1.37
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 1.34
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 1.34
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 1.33
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 1.33
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 1.28
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 1.25
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 1.25
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 1.25
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 1.23
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 1.19
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 1.16
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 1.16
Transcriptome analysis of diverse cell types infected with human cytomegalovirus [RNA-Seq] 1.15
The cytokine environment influence on human skin-derived T cells 1.08
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 1.07
Transcriptional changes in lymphoma cells induced by LSD1 depletion 1.07
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 1.07
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 1.05
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 1.0
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 0.99
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.99
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 0.97
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 0.96
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 0.94
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 0.94
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.93
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 0.92
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 0.92
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 0.89
Specific molecular signatures underlie response to decitabine in CMML 0.84
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 0.84
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 0.84
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.79
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.79
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 0.78
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 0.77
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 0.77
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 0.77
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 0.73
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 0.73
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 0.73
Transcriptome analysis of diverse cell types infected with human cytomegalovirus 0.73
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 0.7
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 0.61
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 0.61
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.61
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.61
A novel target of EZH1/2 for treatment of mantle cell lymphoma 0.59
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 0.58
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 0.57
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 0.56
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 0.54
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 0.51
NAPRT activation of macrophages 0.51
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 0.5
MHC Transcriptomic landscape at haplotype-specific resolution 0.48
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 0.47
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 0.46
Gene expression activation in CLL mediated by MSCs contact 0.45
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. 0.43
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] 0.43
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 0.4
Expression analysis of the TAF1 syndrome 0.38
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 0.34
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 0.34
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 0.33
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 0.32
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 0.31
Oncogenic roles of ARID5B in T-ALL 0.31
Dermal endothelial cells of type 2 diabetic patients 0.3
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 0.29
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 0.25
Clinker: visualizing fusion genes detected in RNA-seq data 0.25
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 0.25
Anti-Inflammatory Effects of Budesonide in Human Fetal Lung 0.23
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 0.22
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 0.22
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 0.19
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 0.13
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 0.12
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 0.11
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 0.1
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 0.1
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 0.1
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 0.07
Kinetics of cytokine receptor trafficking determine signaling and functional selectivity 0.04
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.03
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 0.02
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.02
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation